The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
PsychopharmacologyFull Access

Treating Youth With Antipsychotics: What Does the Evidence Say?

Published Online:

Abstract

Side effects stemming from antipsychotic use in children are similar to those experienced by adults, but children may be at greater risk for such events, says Christoph Correll, M.D.

Photo: Christoph Correll, M.D.

Christoph Correll, M.D.

Hostra NS-LIJ School of Medicine

As headlines bring more attention to the use of antipsychotics in children and adolescents, Christoph Correll, M.D., a professor of psychiatry and molecular medicine at Hofstra North Shore-LIJ School of Medicine and medical director of the Recognition and Prevention program at the Zucker Hillside Hospital in New York, provides insight on the latest evidence-based treatments involving the use of antipsychotic medications in youth with such diagnoses as psychosis, bipolar disorder, or attention-deficit/hyperactivity disorder. He was interviewed at the 2015 American Academy of Child and Adolescent Psychiatry Annual Meeting.

View the video.